Duality Biotherapeutics, Inc. (HKG:9606)

Duality Biotherapeutics Statistics

Total Valuation

HKG:9606 has a market cap or net worth of HKD 31.06 billion. The enterprise value is 27.07 billion.

Market Cap	31.06B
Enterprise Value	27.07B

Important Dates

The next estimated earnings date is Thursday, April 2, 2026.

Earnings Date	Apr 2, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:9606 has 89.42 million shares outstanding.

Current Share Class	89.42M
Shares Outstanding	89.42M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	13.03%
Owned by Institutions (%)	25.84%
Float	44.63M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.06
PB Ratio	9.73
P/TBV Ratio	9.87
P/FCF Ratio	40.92
P/OCF Ratio	40.66
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-8.73
EV / Sales	11.38
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	35.67

Financial Position

The company has a current ratio of 4.73, with a Debt / Equity ratio of 0.02.

Current Ratio	4.73
Quick Ratio	4.66
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.10
Interest Coverage	-304.79

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-6.36%
Revenue Per Employee	12.45M
Profits Per Employee	-16.24M
Employee Count	170
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, HKG:9606 has paid 11.28 million in taxes.

Income Tax	11.28M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	328.39
200-Day Moving Average	n/a
Relative Strength Index (RSI)	54.38
Average Volume (20 Days)	844,955

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9606 had revenue of HKD 2.38 billion and -3.10 billion in losses. Loss per share was -124.82.

Revenue	2.38B
Gross Profit	883.05M
Operating Income	-230.79M
Pretax Income	-3.09B
Net Income	-3.10B
EBITDA	-225.66M
EBIT	-230.79M
Loss Per Share	-124.82

Balance Sheet

The company has 4.06 billion in cash and 74.40 million in debt, with a net cash position of 3.99 billion or 44.60 per share.

Cash & Cash Equivalents	4.06B
Total Debt	74.40M
Net Cash	3.99B
Net Cash Per Share	44.60
Equity (Book Value)	3.19B
Book Value Per Share	36.25
Working Capital	3.53B

Cash Flow

In the last 12 months, operating cash flow was 763.93 million and capital expenditures -4.80 million, giving a free cash flow of 759.13 million.

Operating Cash Flow	763.93M
Capital Expenditures	-4.80M
Free Cash Flow	759.13M
FCF Per Share	8.49

Margins

Gross margin is 37.13%, with operating and profit margins of -9.70% and -130.43%.

Gross Margin	37.13%
Operating Margin	-9.70%
Pretax Margin	-129.96%
Profit Margin	-130.43%
EBITDA Margin	-9.49%
EBIT Margin	-9.70%
FCF Margin	31.92%

Dividends & Yields

HKG:9606 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-9.99%
FCF Yield	2.44%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9606 has an Altman Z-Score of 8.27 and a Piotroski F-Score of 2.

Altman Z-Score	8.27
Piotroski F-Score	2